select a format

Single User License
USD 1500 INR 0
Site License
USD 3000 INR 0
Corporate User License
USD 4500 INR 0


Request a quote
Request a Customized research
Request for Sample Report


Recent Viewed Reports

Why Ken Reasearch?


The report sent to us was on the point, and its information was quite extensive, well structured, and well researched. More importantly what we valued was your response time and professionalism. As a leading global consulting firm, our clients expect high quality deliverables in short periods of time, so a reliable research partner is essential. For the price that you have charged the quality of your services were exceptional. We look forward to continue our relationship with your team on future engagements.... "Senior Associate, Booz Allen Hamilton"

This is with regards to your report on India PVC pipes and fitting market outlook industry outlook to 2019. This is a very well written report and accept my compliments on the same.... ... "Mohit Mittal, Consultant, KPMG Advisory Services"

I am pleased to see the very useful and productive information in the report..Very well structured great presentation reflect professionalism in your research studies.... "Mustafa Masood, Financial Analyst , Coldwell Banker Riyadh"

While we still are studying and analysing your reports about Vietnam & Thailand, we would like to convey to your research team that they have done a very good job in compiling so much of information together. We hope to see more of such well researched reports. All the best & keep it up. ... "Prashant Bhagwat,General Manager, Mahindra"

We would like to appreciate Ken Research for their great efforts and wonderful support in providing the Market Intelligence Report for ITPC. The information, statistics and research are well understandable and very clear to the point. We are happy with Ken research for their good client service, on-time delivery of the report and as said the report itself. Thank you Ken research for bringing the valuable output for us. We would be looking forward to have more research with you in the near future. Wish you a success in your business!... "Jestin Mathew, Indonesian Trade Promotion Center"

Rexahn Pharmaceuticals, Inc.-Product Pipeline Review-2015

Rexahn Pharmaceuticals, Inc.-Product Pipeline Review-2015

  • Products Id :- GMDHC06965CDB
  • |
  • Pages: 40
  • |
  • April 2015
  • |
  • |
  Request for Sample Report

Executive Summary

Rexahn Pharmaceuticals, Inc.-Product Pipeline Review-2015


Global Markets Direct's, 'Rexahn Pharmaceuticals, Inc.-Product Pipeline Review-2015', provides an overview of the Rexahn Pharmaceuticals, Inc.'s pharmaceutical research and development focus.

This report provides comprehensive information on the current therapeutic developmental pipeline of Rexahn Pharmaceuticals, Inc.'s, complete with comparative analysis at various stages, therapeutics assessment by drug target, mechanism of action (MoA), route of administration (RoA) and molecule type. It also reviews latest updates, and featured news and press releases, along with special features on late-stage and discontinued projects.

Global Markets Direct's report features investigational drugs from across globe covering over 20 therapy areas and nearly 3,000 indications. The report is built using data and information sourced from Global Markets Direct's proprietary databases, Company/University websites, SEC filings, investor presentations and featured press releases from company/university sites and industry-specific third party sources, put together by Global Markets Direct's team. Drug profiles/records featured in the report undergoes periodic updation following a stringent set of processes that ensures that all the profiles are updated with the latest set of information. Additionally, processes including live news & deals tracking, browser based alert-box and clinical trials registries tracking ensure that the most recent developments are captured on a real time basis.

The report enhances decision making capabilities and help to create effective counter strategies to gain competitive advantage. It strengthens R&D pipelines by identifying new targets and MOAs to produce first-in-class and best-in-class products.

Note*: Certain sections in the report may be removed or altered based on the availability and relevance of data for the indicated disease.


The report provides brief overview of Rexahn Pharmaceuticals, Inc. including business description, key information and facts, and its locations and subsidiaries

The report reviews current pipeline of Rexahn Pharmaceuticals, Inc.'s human therapeutic division and enlists all their major and minor projects

The report features product description and descriptive mechanism of action for key pipeline products along with the product's developmental history and major milestones

Special feature on out-licensed and partnered product portfolio

The report summarizes all the dormant and discontinued pipeline projects

Latest company statement

Latest news and deals relating to the Rexahn Pharmaceuticals, Inc.'s pipeline products

Reasons To Buy

Evaluate Rexahn Pharmaceuticals, Inc.'s strategic position with total access to detailed information on its product pipeline

Assess the growth potential of Rexahn Pharmaceuticals, Inc. in its therapy areas of focus

Identify new drug targets and therapeutic classes in the Rexahn Pharmaceuticals, Inc.'s R&D portfolio and develop key strategic initiatives to reinforce pipeline in those areas

Exploit in-licensing opportunities by identifying windows of opportunity to fill portfolio gaps

Develop strategic initiatives by understanding the focus areas of Rexahn Pharmaceuticals, Inc. and exploit collaboration and partnership opportunities

Identify emerging players with potentially strong product portfolio and create effective counter-strategies to gain competitive advantage

Plan mergers and acquisitions effectively by identifying the most promising pipeline of Rexahn Pharmaceuticals, Inc.

Develop and design in-licensing and out-licensing strategies by identifying prospective partners with the most attractive projects to enhance and expand business potential and scope

Explore the dormant and discontinued projects of Rexahn Pharmaceuticals, Inc. and identify potential opportunities in those areas

Avoid Intellectual Property Rights related issues

Contact Us:
Ken Research
Ankur Gupta, Head Marketing & Communications
ankur [@]

Table of Contents

Table of Contents 2

List of Tables 4

List of Figures 4

Rexahn Pharmaceuticals, Inc. Snapshot 5

Rexahn Pharmaceuticals, Inc. Overview 5

Key Information 5

Key Facts 5

Rexahn Pharmaceuticals, Inc.-Research and Development Overview 6

Key Therapeutic Areas 6

Rexahn Pharmaceuticals, Inc.-Pipeline Review 9

Pipeline Products by Stage of Development 9

Pipeline Products-Monotherapy 10

Rexahn Pharmaceuticals, Inc.-Pipeline Products Glance 11

Rexahn Pharmaceuticals, Inc.-Clinical Stage Pipeline Products 11

Phase II Products/Combination Treatment Modalities 11

Phase I Products/Combination Treatment Modalities 12

Rexahn Pharmaceuticals, Inc.-Early Stage Pipeline Products 13

Preclinical Products/Combination Treatment Modalities 13

Discovery Products/Combination Treatment Modalities 14

Rexahn Pharmaceuticals, Inc.-Unknown Stage Pipeline Products 15

Unknown Products/Combination Treatment Modalities 15

Rexahn Pharmaceuticals, Inc.-Drug Profiles 16

RX-0201 16

Product Description 16

Mechanism of Action 16

R&D Progress 16

RX-3117 18

Product Description 18

Mechanism of Action 18

R&D Progress 18

RX-5902 19

Product Description 19

Mechanism of Action 19

R&D Progress 19

RX-0047N 20

Product Description 20

Mechanism of Action 20

R&D Progress 20

RX-0201N 21

Product Description 21

Mechanism of Action 21

R&D Progress 21

RX-1792 22

Product Description 22

Mechanism of Action 22

R&D Progress 22

RX-21101 23

Product Description 23

Mechanism of Action 23

R&D Progress 23

RX-8243 24

Product Description 24

Mechanism of Action 24

R&D Progress 24

Small Molecules for Cancer 25

Product Description 25

Mechanism of Action 25

R&D Progress 25

Rexahn Pharmaceuticals, Inc.-Pipeline Analysis 26

Rexahn Pharmaceuticals, Inc.-Pipeline Products by Target 26

Rexahn Pharmaceuticals, Inc.-Pipeline Products by Route of Administration 27

Rexahn Pharmaceuticals, Inc.-Pipeline Products by Molecule Type 28

Rexahn Pharmaceuticals, Inc.-Pipeline Products by Mechanism of Action 29

Rexahn Pharmaceuticals, Inc.-Recent Pipeline Updates 30

Rexahn Pharmaceuticals, Inc.-Dormant Projects 37

Rexahn Pharmaceuticals, Inc.-Locations And Subsidiaries 38

Head Office 38

Appendix 39

Methodology 39

Coverage 39

Secondary Research 39

Primary Research 39

Expert Panel Validation 39

Contact Us 39

Disclaimer 40

List of Tables

Rexahn Pharmaceuticals, Inc., Key Information 5

Rexahn Pharmaceuticals, Inc., Key Facts 5

Rexahn Pharmaceuticals, Inc.-Pipeline by Indication, 2015 8

Rexahn Pharmaceuticals, Inc.-Pipeline by Stage of Development, 2015 9

Rexahn Pharmaceuticals, Inc.-Monotherapy Products in Pipeline, 2015 10

Rexahn Pharmaceuticals, Inc.-Phase II, 2015 11

Rexahn Pharmaceuticals, Inc.-Phase I, 2015 12

Rexahn Pharmaceuticals, Inc.-Preclinical, 2015 13

Rexahn Pharmaceuticals, Inc.-Discovery, 2015 14

Rexahn Pharmaceuticals, Inc.-Unknown, 2015 15

Rexahn Pharmaceuticals, Inc.-Pipeline by Target, 2015 26

Rexahn Pharmaceuticals, Inc.-Pipeline by Route of Administration, 2015 27

Rexahn Pharmaceuticals, Inc.-Pipeline by Molecule Type, 2015 28

Rexahn Pharmaceuticals, Inc.-Pipeline Products by Mechanism of Action, 2015 29

Rexahn Pharmaceuticals, Inc.-Recent Pipeline Updates, 2015 30

Rexahn Pharmaceuticals, Inc.-Dormant Developmental Projects,2015 37

List of Figures

Rexahn Pharmaceuticals, Inc.-Pipeline by Top 10 Indication, 2015 7

Rexahn Pharmaceuticals, Inc.-Pipeline by Stage of Development, 2015 9

Rexahn Pharmaceuticals, Inc.-Monotherapy Products in Pipeline, 2015 10

Rexahn Pharmaceuticals, Inc.-Pipeline by Top 10 Target, 2015 26

Rexahn Pharmaceuticals, Inc.-Pipeline by Top 10 Route of Administration, 2015 27

Rexahn Pharmaceuticals, Inc.-Pipeline by Top 10 Molecule Type, 2015 28

Rexahn Pharmaceuticals, Inc.-Pipeline Products by Top 10 Mechanism of Action, 2015 29

Single User License:
Report can be used by individual purchaser only

Site License:
Report can be shared by unlimited users within one corporate location, e.g. a regional office

Corporate User License:
Report can be shared globally by unlimited users within the purchasing corporation e.g. all employees of a single company

To know more information on Purchase by Section, please send a mail to query [@]

Current R&D Portfolio of Rexahn Pharmaceuticals, Inc.; Rexahn Pharmaceuticals, Inc. - Key Therapeutics; Rexahn Pharmaceuticals, Inc. - Pipeline Overview and Promising Molecules; Rexahn Pharmaceuticals, Inc. - News; Rexahn Pharmaceuticals, Inc. - Latest Updates; Rexahn Pharmaceuticals, Inc. - Pipeline; Rexahn Pharmaceuticals, Inc. - Discontinued/Dormant Projects

Related Products in vertical
Other reports by publisher
Ken Research Pvt. Ltd. Unit 14, Tower B3, Spaze I Tech Business Park, Sohna Road, sector 49
     Gurgaon, Haryana - 122001, India


Company Brochure

Engage with Us

query [@]